NCT03258606View on ClinicalTrials.gov

Characteristics and Outcomes of a Capacity-to-Consent Assessment Service

CompletedOBSERVATIONAL
Enrollment

1,098

Participants

Timeline

Start Date

June 26, 2017

Primary Completion Date

August 10, 2018

Study Completion Date

April 9, 2021

Conditions
Cognitive Dysfunction
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT03258606 - Characteristics and Outcomes of a Capacity-to-Consent Assessment Service | Biotech Hunter | Biotech Hunter